FACTANKER
Altamira Therapeutics Ltd.: xbrl:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
Value
{"unit": "CHF", "value": 13031}
Period
2020-01-01 – 2020-12-31
Status
current
Entity
Altamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-21-018959
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER,
https://factanker.com/fact/265231f4-2f45-4c1e-b2fb-04d680593553
History
no predecessors — first report